On August 30, the National Multiple Sclerosis Awareness Day was celebrated, and in this context the question arises: has the treatment for multiple sclerosis patients undergone any changes during the coronavirus pandemic?

To answer, the superintendent of Teaching, Research, Development and Innovation of the Instituto do Cebra do RS, the neurologist Douglas Sato, was invited to give an interview to the Association of People with Multiple Sclerosis of Santa Maria and region ( APEMSMAR).

In a live recorded on youtube, he talks for more than an hour about the care that a person with multiple sclerosis should have during this pandemic period, the use of medicines and the consequences of this disease. Don't miss it, click here.

What is APEMSMAR?

APEMSMAR (Association of Multiple Sclerosis Patients of Santa Maria and region) is a non-profit organization that was born in 2001, with a small group coordinated by patients and health professionals. In 2002, it became known as Grupo Girassol. In 2004, it was idealized as an association and gained the adhesion of patients with Ataxia (irregular muscle coordination). In March 2009, he received the certificate of association and CNPJ.